D
Nurix Therapeutics, Inc.
NRIX
$13.59
$0.403.03%
D
Sell
2/8/2024Upgraded
Nurix Therapeutics, Inc. (NRIX) was upgraded to D- from E+ on 2/8/2024 due to an increase in the volatility index and total return index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D- from E+ on 2/8/2024 due to an increase in the volatility index and total return index.
E
Sell
1/24/2024Downgrade
Nurix Therapeutics, Inc. (NRIX) was downgraded to E+ from D- on 1/24/2024 due to a decline in the volatility index and valuation index.
Nurix Therapeutics, Inc. (NRIX) was downgraded to E+ from D- on 1/24/2024 due to a decline in the volatility index and valuation index.
D
Sell
12/7/2023Upgraded
Nurix Therapeutics, Inc. (NRIX) was upgraded to D- from E+ on 12/7/2023 due to an increase in the volatility index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D- from E+ on 12/7/2023 due to an increase in the volatility index.
E
Sell
11/8/2023Downgrade
Nurix Therapeutics, Inc. (NRIX) was downgraded to E+ from D- on 11/8/2023 due to a decline in the total return index and volatility index.
Nurix Therapeutics, Inc. (NRIX) was downgraded to E+ from D- on 11/8/2023 due to a decline in the total return index and volatility index.
D
Sell
10/13/2023Upgraded
Nurix Therapeutics, Inc. (NRIX) was upgraded to D- from E+ on 10/13/2023 due to an increase in the volatility index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D- from E+ on 10/13/2023 due to an increase in the volatility index.
E
Sell
10/12/2023Downgrade
Nurix Therapeutics, Inc. (NRIX) was downgraded to E+ from D- on 10/12/2023 due to a decline in the volatility index and total return index.
Nurix Therapeutics, Inc. (NRIX) was downgraded to E+ from D- on 10/12/2023 due to a decline in the volatility index and total return index.
D
Sell
9/22/2023Upgraded
Nurix Therapeutics, Inc. (NRIX) was upgraded to D- from E+ on 9/22/2023 due to an increase in the volatility index and total return index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D- from E+ on 9/22/2023 due to an increase in the volatility index and total return index.
E
Sell
9/7/2023Downgrade
Nurix Therapeutics, Inc. (NRIX) was downgraded to E+ from D- on 9/7/2023 due to a decline in the volatility index.
Nurix Therapeutics, Inc. (NRIX) was downgraded to E+ from D- on 9/7/2023 due to a decline in the volatility index.
D
Sell
8/17/2023Upgraded
Nurix Therapeutics, Inc. (NRIX) was upgraded to D- from E+ on 8/17/2023 due to an increase in the volatility index, total return index and valuation index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D- from E+ on 8/17/2023 due to an increase in the volatility index, total return index and valuation index.
E
Sell
8/2/2023Downgrade
Nurix Therapeutics, Inc. (NRIX) was downgraded to E+ from D- on 8/2/2023 due to a decline in the growth index and volatility index.
Nurix Therapeutics, Inc. (NRIX) was downgraded to E+ from D- on 8/2/2023 due to a decline in the growth index and volatility index.
D
Sell
7/14/2023Upgraded
Nurix Therapeutics, Inc. (NRIX) was upgraded to D- from E+ on 7/14/2023 due to a large increase in the growth index, volatility index and solvency index. Total revenue increased 141.83% from $12.69M to $30.68M, operating cash flow increased 61.88% from -$48.45M to -$18.47M, and earnings per share increased from -$0.7539 to -$0.4474.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D- from E+ on 7/14/2023 due to a large increase in the growth index, volatility index and solvency index. Total revenue increased 141.83% from $12.69M to $30.68M, operating cash flow increased 61.88% from -$48.45M to -$18.47M, and earnings per share increased from -$0.7539 to -$0.4474.
E
Sell
7/12/2023Downgrade
Nurix Therapeutics, Inc. (NRIX) was downgraded to E+ from D- on 7/12/2023 due to a decline in the volatility index.
Nurix Therapeutics, Inc. (NRIX) was downgraded to E+ from D- on 7/12/2023 due to a decline in the volatility index.
D
Sell
6/21/2023Upgraded
Nurix Therapeutics, Inc. (NRIX) was upgraded to D- from E+ on 6/21/2023 due to an increase in the volatility index and total return index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D- from E+ on 6/21/2023 due to an increase in the volatility index and total return index.
E
Sell
6/5/2023Downgrade
Nurix Therapeutics, Inc. (NRIX) was downgraded to E+ from D- on 6/5/2023 due to a decline in the volatility index and total return index.
Nurix Therapeutics, Inc. (NRIX) was downgraded to E+ from D- on 6/5/2023 due to a decline in the volatility index and total return index.
D
Sell
5/15/2023Upgraded
Nurix Therapeutics, Inc. (NRIX) was upgraded to D- from E+ on 5/15/2023 due to an increase in the volatility index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D- from E+ on 5/15/2023 due to an increase in the volatility index.
E
Sell
4/28/2023Downgrade
Nurix Therapeutics, Inc. (NRIX) was downgraded to E+ from D- on 4/28/2023 due to a decline in the total return index, volatility index and valuation index.
Nurix Therapeutics, Inc. (NRIX) was downgraded to E+ from D- on 4/28/2023 due to a decline in the total return index, volatility index and valuation index.
D
Sell
3/14/2023Downgrade
Nurix Therapeutics, Inc. (NRIX) was downgraded to D- from D on 3/14/2023 due to a decline in the total return index and volatility index.
Nurix Therapeutics, Inc. (NRIX) was downgraded to D- from D on 3/14/2023 due to a decline in the total return index and volatility index.
D
Sell
2/10/2023Upgraded
Nurix Therapeutics, Inc. (NRIX) was upgraded to D from D- on 02/10/2023.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D from D- on 02/10/2023.
D
Sell
2/8/2023Downgrade
Nurix Therapeutics, Inc. (NRIX) was downgraded to D- from D on 2/8/2023 due to a decline in the growth index. Operating cash flow declined 40.69% from -$32.91M to -$46.31M, total revenue declined 5.61% from $11.43M to $10.79M, and EBIT declined 2.19% from -$45.72M to -$46.72M.
Nurix Therapeutics, Inc. (NRIX) was downgraded to D- from D on 2/8/2023 due to a decline in the growth index. Operating cash flow declined 40.69% from -$32.91M to -$46.31M, total revenue declined 5.61% from $11.43M to $10.79M, and EBIT declined 2.19% from -$45.72M to -$46.72M.
D
Sell
7/8/2022Upgraded
Nurix Therapeutics, Inc. (NRIX) was upgraded to D from D- on 7/8/2022 due to a noticeable increase in the growth index and volatility index. Operating cash flow increased 22.79% from -$42.63M to -$32.91M, and total revenue increased 18.82% from $9.62M to $11.43M.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D from D- on 7/8/2022 due to a noticeable increase in the growth index and volatility index. Operating cash flow increased 22.79% from -$42.63M to -$32.91M, and total revenue increased 18.82% from $9.62M to $11.43M.
D
Sell
5/31/2022Upgraded
Nurix Therapeutics, Inc. (NRIX) was upgraded to D- from E+ on 5/31/2022 due to an increase in the valuation index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D- from E+ on 5/31/2022 due to an increase in the valuation index.
E
Sell
5/13/2022Downgrade
Nurix Therapeutics, Inc. (NRIX) was downgraded to E+ from D- on 5/13/2022 due to a decline in the solvency index, total return index and volatility index.
Nurix Therapeutics, Inc. (NRIX) was downgraded to E+ from D- on 5/13/2022 due to a decline in the solvency index, total return index and volatility index.
D
Sell
4/20/2022Downgrade
Nurix Therapeutics, Inc. (NRIX) was downgraded to D- from D on 4/20/2022 due to a large decline in the total return index, volatility index and growth index. Operating cash flow declined 37.91% from -$30.91M to -$42.63M, EBIT declined 12.62% from -$37.95M to -$42.74M, and earnings per share declined from -$0.8462 to -$0.9517.
Nurix Therapeutics, Inc. (NRIX) was downgraded to D- from D on 4/20/2022 due to a large decline in the total return index, volatility index and growth index. Operating cash flow declined 37.91% from -$30.91M to -$42.63M, EBIT declined 12.62% from -$37.95M to -$42.74M, and earnings per share declined from -$0.8462 to -$0.9517.
D
Sell
1/18/2022Downgrade
Nurix Therapeutics, Inc. (NRIX) was downgraded to D from D+ on 1/18/2022 due to a decline in the total return index and volatility index.
Nurix Therapeutics, Inc. (NRIX) was downgraded to D from D+ on 1/18/2022 due to a decline in the total return index and volatility index.
D
Sell
1/3/2022Upgraded
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from D on 1/3/2022 due to an increase in the total return index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from D on 1/3/2022 due to an increase in the total return index.
D
Sell
12/17/2021Downgrade
Nurix Therapeutics, Inc. (NRIX) was downgraded to D from D+ on 12/17/2021 due to a substantial decline in the total return index.
Nurix Therapeutics, Inc. (NRIX) was downgraded to D from D+ on 12/17/2021 due to a substantial decline in the total return index.
D
Sell
11/22/2021Upgraded
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from D- on 11/22/2021 due to an increase in the valuation index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from D- on 11/22/2021 due to an increase in the valuation index.
D
Sell
11/8/2021Downgrade
Nurix Therapeutics, Inc. (NRIX) was downgraded to D- from D+ on 11/8/2021 due to a decline in the solvency index and valuation index. The quick ratio declined from 8.36 to 6.89.
Nurix Therapeutics, Inc. (NRIX) was downgraded to D- from D+ on 11/8/2021 due to a decline in the solvency index and valuation index. The quick ratio declined from 8.36 to 6.89.
D
Sell
10/5/2021Upgraded
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from D on 10/5/2021 due to an increase in the volatility index and total return index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from D on 10/5/2021 due to an increase in the volatility index and total return index.
D
Sell
8/17/2021Downgrade
Nurix Therapeutics, Inc. (NRIX) was downgraded to D from D+ on 8/17/2021 due to a decline in the volatility index, total return index and valuation index.
Nurix Therapeutics, Inc. (NRIX) was downgraded to D from D+ on 8/17/2021 due to a decline in the volatility index, total return index and valuation index.
D
Sell
8/2/2021Upgraded
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from D on 8/2/2021 due to an increase in the growth index, solvency index and valuation index. Total revenue increased 41.51% from $5.01M to $7.09M, the quick ratio increased from 6.4 to 8.36, and earnings per share increased from -$0.626 to -$0.6023.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from D on 8/2/2021 due to an increase in the growth index, solvency index and valuation index. Total revenue increased 41.51% from $5.01M to $7.09M, the quick ratio increased from 6.4 to 8.36, and earnings per share increased from -$0.626 to -$0.6023.
D
Sell
4/15/2021Upgraded
Nurix Therapeutics, Inc. (NRIX) was upgraded to D from E on 4/15/2021 due to a large increase in the total return index, solvency index and growth index. Operating cash flow increased 139.32% from -$20.48M to $8.05M.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D from E on 4/15/2021 due to a large increase in the total return index, solvency index and growth index. Operating cash flow increased 139.32% from -$20.48M to $8.05M.
E
Sell
4/14/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 4/14/2021 due to a large increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 4/14/2021 due to a large increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
E
Sell
4/13/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 4/13/2021 due to a large increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 4/13/2021 due to a large increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
E
Sell
4/12/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 4/12/2021 due to a large increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 4/12/2021 due to a large increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
E
Sell
4/9/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 4/9/2021 due to a large increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 4/9/2021 due to a large increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
E
Sell
4/8/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 4/8/2021 due to a large increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 4/8/2021 due to a large increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
E
Sell
4/7/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 4/7/2021 due to a large increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 4/7/2021 due to a large increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
E
Sell
4/6/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 4/6/2021 due to a large increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 4/6/2021 due to a large increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
E
Sell
4/5/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 4/5/2021 due to a large increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 4/5/2021 due to a large increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
E
Sell
4/1/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 4/1/2021 due to a large increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 4/1/2021 due to a large increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
E
Sell
3/31/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 3/31/2021 due to a large increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 3/31/2021 due to a large increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
E
Sell
3/30/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 3/30/2021 due to a large increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 3/30/2021 due to a large increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
E
Sell
3/29/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 3/29/2021 due to a large increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 3/29/2021 due to a large increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
E
Sell
3/26/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 3/26/2021 due to a large increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 3/26/2021 due to a large increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
E
Sell
3/25/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 3/25/2021 due to a large increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 3/25/2021 due to a large increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
E
Sell
3/24/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 3/24/2021 due to a large increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 3/24/2021 due to a large increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
E
Sell
3/23/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 3/23/2021 due to a major increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 3/23/2021 due to a major increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
E
Sell
3/22/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 3/22/2021 due to a major increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 3/22/2021 due to a major increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
E
Sell
3/19/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 3/19/2021 due to a major increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 3/19/2021 due to a major increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
E
Sell
3/18/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 3/18/2021 due to a major increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 3/18/2021 due to a major increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
E
Sell
3/17/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 3/17/2021 due to a major increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 3/17/2021 due to a major increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
E
Sell
3/16/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 3/16/2021 due to a major increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 3/16/2021 due to a major increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
E
Sell
3/15/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 3/15/2021 due to a major increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 3/15/2021 due to a major increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
E
Sell
3/12/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 3/12/2021 due to a major increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 3/12/2021 due to a major increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
E
Sell
3/11/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 3/11/2021 due to a large increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 3/11/2021 due to a large increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
E
Sell
3/10/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 3/10/2021 due to a large increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 3/10/2021 due to a large increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
E
Sell
3/9/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 3/9/2021 due to a large increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 3/9/2021 due to a large increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
E
Sell
3/8/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 3/8/2021 due to a large increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 3/8/2021 due to a large increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
E
Sell
3/5/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 3/5/2021 due to a large increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 3/5/2021 due to a large increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
E
Sell
3/4/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 3/4/2021 due to a large increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 3/4/2021 due to a large increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
E
Sell
3/3/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 3/3/2021 due to a large increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 3/3/2021 due to a large increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
E
Sell
3/2/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 3/2/2021 due to a major increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 3/2/2021 due to a major increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
E
Sell
3/1/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 3/1/2021 due to a major increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 3/1/2021 due to a major increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
E
Sell
2/26/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 2/26/2021 due to a major increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 2/26/2021 due to a major increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
E
Sell
2/25/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 2/25/2021 due to a major increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 2/25/2021 due to a major increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
E
Sell
2/24/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 2/24/2021 due to a major increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 2/24/2021 due to a major increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
E
Sell
2/23/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 2/23/2021 due to a major increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 2/23/2021 due to a major increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
E
Sell
2/22/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 2/22/2021 due to a major increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 2/22/2021 due to a major increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
E
Sell
2/19/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 2/19/2021 due to a major increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 2/19/2021 due to a major increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
E
Sell
2/18/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 2/18/2021 due to a major increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 2/18/2021 due to a major increase in the total return index, growth index and solvency index. Total revenue increased 63.75% from $4.09M to $6.69M, and earnings per share increased from -$0.59 to -$0.5145.
E
Sell
2/17/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 2/17/2021 due to a major increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 2/17/2021 due to a major increase in the total return index and solvency index.
E
Sell
2/16/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 2/16/2021 due to a major increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 2/16/2021 due to a major increase in the total return index and solvency index.
E
Sell
2/12/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 2/12/2021 due to a major increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 2/12/2021 due to a major increase in the total return index and solvency index.
E
Sell
2/11/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 2/11/2021 due to a major increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 2/11/2021 due to a major increase in the total return index and solvency index.
E
Sell
2/10/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 2/10/2021 due to a major increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 2/10/2021 due to a major increase in the total return index and solvency index.
E
Sell
2/9/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 2/9/2021 due to a major increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 2/9/2021 due to a major increase in the total return index and solvency index.
E
Sell
2/8/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 2/8/2021 due to a major increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 2/8/2021 due to a major increase in the total return index and solvency index.
E
Sell
2/5/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 2/5/2021 due to a major increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 2/5/2021 due to a major increase in the total return index and solvency index.
E
Sell
2/4/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 2/4/2021 due to a major increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 2/4/2021 due to a major increase in the total return index and solvency index.
E
Sell
2/3/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 2/3/2021 due to a major increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 2/3/2021 due to a major increase in the total return index and solvency index.
E
Sell
2/2/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 2/2/2021 due to a major increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 2/2/2021 due to a major increase in the total return index and solvency index.
E
Sell
2/1/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 2/1/2021 due to a major increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 2/1/2021 due to a major increase in the total return index and solvency index.
E
Sell
1/29/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 1/29/2021 due to a major increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 1/29/2021 due to a major increase in the total return index and solvency index.
E
Sell
1/28/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 1/28/2021 due to a major increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 1/28/2021 due to a major increase in the total return index and solvency index.
E
Sell
1/27/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 1/27/2021 due to a major increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 1/27/2021 due to a major increase in the total return index and solvency index.
E
Sell
1/26/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 1/26/2021 due to a major increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 1/26/2021 due to a major increase in the total return index and solvency index.
E
Sell
1/25/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 1/25/2021 due to a major increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 1/25/2021 due to a major increase in the total return index and solvency index.
E
Sell
1/22/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 1/22/2021 due to a large increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 1/22/2021 due to a large increase in the total return index and solvency index.
E
Sell
1/21/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 1/21/2021 due to a large increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 1/21/2021 due to a large increase in the total return index and solvency index.
E
Sell
1/20/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 1/20/2021 due to a large increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 1/20/2021 due to a large increase in the total return index and solvency index.
E
Sell
1/19/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 1/19/2021 due to a large increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 1/19/2021 due to a large increase in the total return index and solvency index.
E
Sell
1/15/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 1/15/2021 due to a large increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 1/15/2021 due to a large increase in the total return index and solvency index.
E
Sell
1/14/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 1/14/2021 due to a large increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 1/14/2021 due to a large increase in the total return index and solvency index.
E
Sell
1/13/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 1/13/2021 due to a large increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 1/13/2021 due to a large increase in the total return index and solvency index.
E
Sell
1/12/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 1/12/2021 due to a large increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 1/12/2021 due to a large increase in the total return index and solvency index.
E
Sell
1/11/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 1/11/2021 due to a large increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 1/11/2021 due to a large increase in the total return index and solvency index.
E
Sell
1/8/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 1/8/2021 due to a large increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 1/8/2021 due to a large increase in the total return index and solvency index.
E
Sell
1/7/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 1/7/2021 due to a large increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 1/7/2021 due to a large increase in the total return index and solvency index.
E
Sell
1/6/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 1/6/2021 due to a large increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 1/6/2021 due to a large increase in the total return index and solvency index.
E
Sell
1/5/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 1/5/2021 due to a large increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 1/5/2021 due to a large increase in the total return index and solvency index.
E
Sell
1/4/2021None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 1/4/2021 due to a large increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 1/4/2021 due to a large increase in the total return index and solvency index.
E
Sell
12/31/2020None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 12/31/2020 due to a large increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 12/31/2020 due to a large increase in the total return index and solvency index.
E
Sell
12/30/2020None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 12/30/2020 due to a large increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 12/30/2020 due to a large increase in the total return index and solvency index.
E
Sell
12/29/2020None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 12/29/2020 due to a large increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 12/29/2020 due to a large increase in the total return index and solvency index.
E
Sell
12/28/2020None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 12/28/2020 due to a large increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 12/28/2020 due to a large increase in the total return index and solvency index.
E
Sell
12/24/2020None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 12/24/2020 due to a large increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 12/24/2020 due to a large increase in the total return index and solvency index.
E
Sell
12/23/2020None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 12/23/2020 due to a large increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 12/23/2020 due to a large increase in the total return index and solvency index.
E
Sell
12/22/2020None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 12/22/2020 due to a large increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 12/22/2020 due to a large increase in the total return index and solvency index.
E
Sell
12/21/2020None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 12/21/2020 due to a large increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 12/21/2020 due to a large increase in the total return index and solvency index.
E
Sell
12/18/2020None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 12/18/2020 due to a large increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 12/18/2020 due to a large increase in the total return index and solvency index.
E
Sell
12/17/2020None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 12/17/2020 due to a large increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 12/17/2020 due to a large increase in the total return index and solvency index.
E
Sell
12/16/2020None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 12/16/2020 due to a large increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 12/16/2020 due to a large increase in the total return index and solvency index.
E
Sell
12/15/2020None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 12/15/2020 due to a large increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 12/15/2020 due to a large increase in the total return index and solvency index.
E
Sell
12/14/2020None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 12/14/2020 due to a large increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 12/14/2020 due to a large increase in the total return index and solvency index.
E
Sell
12/11/2020None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 12/11/2020 due to a large increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 12/11/2020 due to a large increase in the total return index and solvency index.
E
Sell
12/10/2020None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 12/10/2020 due to a large increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 12/10/2020 due to a large increase in the total return index and solvency index.
E
Sell
12/9/2020None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 12/9/2020 due to a large increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 12/9/2020 due to a large increase in the total return index and solvency index.
E
Sell
12/8/2020None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 12/8/2020 due to a large increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 12/8/2020 due to a large increase in the total return index and solvency index.
E
Sell
12/7/2020None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 12/7/2020 due to a large increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 12/7/2020 due to a large increase in the total return index and solvency index.
E
Sell
12/4/2020None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 12/4/2020 due to a large increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 12/4/2020 due to a large increase in the total return index and solvency index.
E
Sell
12/3/2020None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 12/3/2020 due to a large increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 12/3/2020 due to a large increase in the total return index and solvency index.
E
Sell
12/2/2020None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 12/2/2020 due to a large increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 12/2/2020 due to a large increase in the total return index and solvency index.
E
Sell
12/1/2020None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 12/1/2020 due to a large increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 12/1/2020 due to a large increase in the total return index and solvency index.
E
Sell
11/30/2020None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 11/30/2020 due to a large increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 11/30/2020 due to a large increase in the total return index and solvency index.
E
Sell
11/27/2020None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 11/27/2020 due to a large increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 11/27/2020 due to a large increase in the total return index and solvency index.
E
Sell
11/23/2020None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 11/23/2020 due to a large increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 11/23/2020 due to a large increase in the total return index and solvency index.
E
Sell
11/20/2020None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 11/20/2020 due to a large increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 11/20/2020 due to a large increase in the total return index and solvency index.
E
Sell
11/19/2020None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 11/19/2020 due to a large increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 11/19/2020 due to a large increase in the total return index and solvency index.
E
Sell
11/18/2020None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 11/18/2020 due to a large increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 11/18/2020 due to a large increase in the total return index and solvency index.
E
Sell
11/17/2020None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 11/17/2020 due to a large increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 11/17/2020 due to a large increase in the total return index and solvency index.
E
Sell
11/16/2020None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 11/16/2020 due to a large increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 11/16/2020 due to a large increase in the total return index and solvency index.
E
Sell
11/12/2020None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 11/12/2020 due to a large increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 11/12/2020 due to a large increase in the total return index and solvency index.
E
Sell
11/10/2020None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 11/10/2020 due to a noticeable increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 11/10/2020 due to a noticeable increase in the total return index and solvency index.
E
Sell
11/9/2020None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 11/9/2020 due to a large increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 11/9/2020 due to a large increase in the total return index and solvency index.
E
Sell
11/5/2020None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 11/5/2020 due to a large increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 11/5/2020 due to a large increase in the total return index and solvency index.
E
Sell
11/4/2020None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 11/4/2020 due to a large increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 11/4/2020 due to a large increase in the total return index and solvency index.
E
Sell
11/3/2020None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 11/3/2020 due to a large increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 11/3/2020 due to a large increase in the total return index and solvency index.
E
Sell
11/2/2020None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 11/2/2020 due to a large increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 11/2/2020 due to a large increase in the total return index and solvency index.
E
Sell
10/30/2020None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 10/30/2020 due to a large increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 10/30/2020 due to a large increase in the total return index and solvency index.
E
Sell
10/29/2020None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 10/29/2020 due to a large increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 10/29/2020 due to a large increase in the total return index and solvency index.
E
Sell
10/28/2020None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 10/28/2020 due to a large increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 10/28/2020 due to a large increase in the total return index and solvency index.
E
Sell
10/27/2020None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 10/27/2020 due to a large increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 10/27/2020 due to a large increase in the total return index and solvency index.
E
Sell
10/26/2020None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 10/26/2020 due to a large increase in the total return index and solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 10/26/2020 due to a large increase in the total return index and solvency index.
E
Sell
10/23/2020None
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 10/23/2020 due to a noticeable increase in the solvency index.
Nurix Therapeutics, Inc. (NRIX) was upgraded to D+ from E on 10/23/2020 due to a noticeable increase in the solvency index.
E
Sell
10/22/2020None
Nurix Therapeutics, Inc. (NRIX) was downgraded to E from E on 10/22/2020.
Nurix Therapeutics, Inc. (NRIX) was downgraded to E from E on 10/22/2020.
E
Sell
10/21/2020None
Nurix Therapeutics, Inc. (NRIX) was downgraded to E from E on 10/21/2020.
Nurix Therapeutics, Inc. (NRIX) was downgraded to E from E on 10/21/2020.
E
Sell
10/20/2020None
Nurix Therapeutics, Inc. (NRIX) was downgraded to E from E on 10/20/2020.
Nurix Therapeutics, Inc. (NRIX) was downgraded to E from E on 10/20/2020.
E
Sell
10/19/2020None
Nurix Therapeutics, Inc. (NRIX) was downgraded to E from E on 10/19/2020.
Nurix Therapeutics, Inc. (NRIX) was downgraded to E from E on 10/19/2020.
E
Sell
10/16/2020None
Nurix Therapeutics, Inc. (NRIX) was downgraded to E from U on 10/16/2020.
Nurix Therapeutics, Inc. (NRIX) was downgraded to E from U on 10/16/2020.
NASDAQ
03/14/2025 4:00PM Eastern
Quotes delayed
